In 2022, it was estimated that for every 1,000 children aged 8 years, around 32 had autism spectrum disorder. This statistic shows the prevalence of autism spectrum disorder among 8-year-old children in the U.S. from 2000 to 2022, per 1,000 children.

The prevalence rate of autism spectrum disorder among children aged eight years in the state Georgia was estimated to be around 32.6 per 1,000 children. Autism spectrum disorder is a developmental disability characterized by deficits in social communication and interaction as well as repetitive behavior, interest, or activity patterns. Autism spectrum disorder in childrenAmong 14 U.S. states with areas that were monitored for autism spectrum disorder in 2022, California had the highest prevalence rates of autism spectrum disorder (ASD) among children aged eight years. In 2022, California’s prevalence rate was estimated to be 53.1 cases per 1,000 children, while the rate was about 18.3 cases per 1,000 children in Indiana. ASD is more common among male than female children, with an estimated 80 male cases per 1,000 children and 23 female cases per 1,000 children in California in 2022. Limitations in a child with autism can vary between individuals and develop over time. In California, the median age of diagnosis among children with an ASD diagnosis with an IQ greater than 70 was 35 months of age, in comparison to 36 months for children with an ASD diagnosis and an IQ less than or equal to 70, indicating a co-occurring intellectual disability. The prevalence of ASD has increased significantly since the late 1960s by about 20 to 30 times. Many studies suggest that this is due to improved awareness and recognition, as well as diagnostic capabilities. Autism is likely caused by a combination of genetics and environmental factors, where people with ASD may have abnormal levels of brain serotonin, which could disrupt early brain development.

The prevalence rate of autism spectrum disorder among four-year-old children in Missouri was around 24.8 per 1,000 children in 2022. Autism spectrum disorder is a developmental disability characterized by deficits in social communication and interaction as well as repetitive behavior, interest, or activity patterns. This statistic displays the estimated prevalence of autism spectrum disorder among children aged four years in select U.S. states in 2022.

The prevalence rate of autism spectrum disorder among male children aged eight years in Georgia was estimated to be around 51 per 1,000 children as of 2022. Autism spectrum disorder is a developmental disability characterized by deficits in social communication and interaction as well as repetitive behavior, interest, or activity patterns. This statistic displays the estimated prevalence of autism spectrum disorder among children aged 8 years in select U.S. states in 2022, by gender.

Input datasets on Ohio Birth and Autism will not be made accessible to the public due to the fact that they include individual-level data with PII. Output data are all available in tabulated form within the published manuscript. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Input data can be obtained from Applications from owners of the data (Children's Hospital and Ohio Department of Health). The tabulated output data is found in the manuscript. Format: Input datasets on Ohio Birth and Autism will not be made accessible to the public due to the fact that they include individual-level data with PII. Output data are all available in tabulated form within the published manuscript (e.g., results of regression models, measures of central tendency, population characteristics, etc.). This dataset is associated with the following publication: Kaufman, J., M. Wright, G. Rice, N. Connolly, K. Bowers, and J. Anixt. AMBIENT OZONE AND FINE PARTICULATE MATTER EXPOSURES AND AUTISM SPECTRUM DISORDER IN METROPOLITAN CINCINNATI, OHIO. ENVIRONMENTAL RESEARCH. Elsevier B.V., Amsterdam, NETHERLANDS, 171: 218-227, (2019).

Introduction: This chapter presents the analysis of physician-diagnosed International Classification of Diseases (ICD version 9) disorders and diseases associated with autism spectrum disorders (ASD) in a 16-year pediatric cohort.Materials and Methods: The sample (n = 47,180; 62% male) consisted of children in the Alberta Health Services Calgary Health Region catchment under the age of 3 years, who received any physician-assigned ICD 9 diagnosis before the age of three between April 1993 and December 31, 1994. There were 111 females and 609 males with ASD diagnosed at any time between 1993 and 2010. The results detail the 16-year odds ratio (OR) associations of ASD diagnosis within the major classes of international classification of diseases (ICD 9) stratified by age and sex in the cohort. Further, for those suffering from ASD and any other disorder or disease, the analysis presents by sex, age, and duration, the proportions of all index physician-assigned ICD diagnoses, arising significantly before and after the index ASD diagnosis.Results: The rate of treated ASD in the cohort was 1 in 65 and the 16-year population rate of ASD was 62 per 10,000. For males with an ASD over the 16 year period, the ORs were significantly greater than the value one for 15 of the 17 main ICD classes and for 10 of the main ICD classes for females. Different age strata presented a more specific account of the main ICD class OR profiles. More specifically, 28 ICD disorders significantly preceded and 95 ICD disorders significantly followed ASD for females. Thirty-eight ICD disorders significantly preceded and 234 ICD disorders significantly followed ASD for males.Conclusions: The results largely confirm past studies focusing on more constrained sets of ASD morbidity. The age-stratified ORs gauge the order of risk in time for the cohort. The proportions of specific ICD disorders arising before and after ASD may be useful in respect to informing basic ASD research and ASD clinical management. Limitations are discussed.

Historical Dataset of Palm Beach School For Autism is provided by PublicSchoolReview and contain statistics on metrics:Total Students Trends Over Years (2004-2023),Total Classroom Teachers Trends Over Years (2008-2023),Distribution of Students By Grade Trends,Student-Teacher Ratio Comparison Over Years (2008-2023),Asian Student Percentage Comparison Over Years (2006-2023),Hispanic Student Percentage Comparison Over Years (2004-2023),Black Student Percentage Comparison Over Years (2004-2023),White Student Percentage Comparison Over Years (2004-2023),Two or More Races Student Percentage Comparison Over Years (2013-2023),Diversity Score Comparison Over Years (2004-2023),Free Lunch Eligibility Comparison Over Years (2004-2023),Reduced-Price Lunch Eligibility Comparison Over Years (2004-2023),Reading and Language Arts Proficiency Comparison Over Years (2010-2022),Math Proficiency Comparison Over Years (2010-2022),Science Proficiency Comparison Over Years (2021-2022),Overall School Rank Trends Over Years (2010-2022),Graduation Rate Comparison Over Years (2017-2022)

Historical Dataset of Autism Model School is provided by PublicSchoolReview and contain statistics on metrics:Total Students Trends Over Years (2002-2023),Total Classroom Teachers Trends Over Years (2003-2023),Distribution of Students By Grade Trends,Student-Teacher Ratio Comparison Over Years (2003-2023),Asian Student Percentage Comparison Over Years (2006-2023),Hispanic Student Percentage Comparison Over Years (2009-2023),Black Student Percentage Comparison Over Years (2002-2023),White Student Percentage Comparison Over Years (2002-2023),Two or More Races Student Percentage Comparison Over Years (2013-2023),Diversity Score Comparison Over Years (2002-2023),Reading and Language Arts Proficiency Comparison Over Years (2010-2022),Math Proficiency Comparison Over Years (2010-2022),Science Proficiency Comparison Over Years (2021-2022),Overall School Rank Trends Over Years (2010-2022),Graduation Rate Comparison Over Years (2013-2022)

The global Autism Spectrum Disorder (ASD) market, valued at $7.78 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 7.6% from 2025 to 2033. This expansion is driven by several key factors. Increased awareness and early diagnosis of ASD are leading to higher treatment rates. Advances in therapeutic interventions, including both pharmacological and non-pharmacological approaches, offer improved outcomes for individuals with ASD and their families. Furthermore, the growing prevalence of ASD globally, coupled with increased investment in research and development of new treatments, fuels market growth. The market is segmented by therapy type (pharmacological and non-pharmacological) and age group (pediatric and adult), reflecting the diverse needs of the ASD population. Pharmacological therapies currently hold a larger market share, due to the established efficacy of certain medications in managing ASD-related symptoms. However, the non-pharmacological segment is experiencing significant growth, driven by rising interest in behavioral therapies and other holistic approaches. The adult segment shows increasing demand as individuals with ASD live longer and require continued support. Regionally, North America and Europe currently dominate the market due to established healthcare infrastructure, higher awareness, and greater access to specialized services. However, Asia-Pacific is expected to witness significant growth in the coming years, fueled by rising disposable incomes, improved healthcare access, and increasing diagnostic capabilities. Competitive pressures within the market are intense, with leading companies focusing on developing innovative therapies, expanding their geographical reach, and strengthening their market positioning through strategic collaborations and acquisitions. Challenges remain, including the high cost of treatments, accessibility issues in certain regions, and the need for more effective treatments for specific ASD-related symptoms. Despite these challenges, the long-term outlook for the ASD market remains positive, driven by sustained investment in research, growing awareness, and an increasing focus on improving the lives of individuals with ASD.

According to a survey carried out in the United States in 2023, 60 percent of those aged between 45 and 64 years of age believed the diagnosis rate for autism was increasing. Furthermore, more than half of over 65 year olds also believed autism diagnoses were increasing.

Historical Dataset of Autism Program - Rawson School is provided by PublicSchoolReview and contain statistics on metrics:Total Students Trends Over Years (2016-2023),Distribution of Students By Grade Trends,Asian Student Percentage Comparison Over Years (2016-2023),Hispanic Student Percentage Comparison Over Years (2016-2023),Black Student Percentage Comparison Over Years (2016-2023),White Student Percentage Comparison Over Years (2016-2023),Diversity Score Comparison Over Years (2016-2023),Free Lunch Eligibility Comparison Over Years (2016-2023)

Historical Dataset of Nyc Autism Charter School East Harlem is provided by PublicSchoolReview and contain statistics on metrics:Total Students Trends Over Years (2009-2023),Total Classroom Teachers Trends Over Years (2009-2023),Student-Teacher Ratio Comparison Over Years (2009-2023),American Indian Student Percentage Comparison Over Years (2019-2023),Asian Student Percentage Comparison Over Years (2009-2023),Hispanic Student Percentage Comparison Over Years (2009-2023),Black Student Percentage Comparison Over Years (2009-2023),White Student Percentage Comparison Over Years (2009-2023),Two or More Races Student Percentage Comparison Over Years (2017-2023),Diversity Score Comparison Over Years (2009-2023),Free Lunch Eligibility Comparison Over Years (2008-2023),Reduced-Price Lunch Eligibility Comparison Over Years (2011-2023),Reading and Language Arts Proficiency Comparison Over Years (2010-2022),Math Proficiency Comparison Over Years (2010-2022),Overall School Rank Trends Over Years (2010-2022)

This dataset is no longer updated as of April 2023.

Basic Metadata Note: Condition is a new addition to 2017. *Rates per 100,000 population. Age-adjusted rates per 100,000 2000 US standard population.

**Blank Cells: Rates not calculated for fewer than 5 events. Rates not calculated in cases where zip code is unknown.

***API: Asian/Pacific Islander. ***AIAN: American Indian/Alaska Native.

Prepared by: County of San Diego, Health & Human Services Agency, Public Health Services, Community Health Statistics Unit, 2019.

Code Source: ICD-9CM - AHRQ HCUP CCS v2015. ICD-10CM - AHRQ HCUP CCS v2018. ICD-10 Mortality - California Department of Public Health, Group Cause of Death Codes 2013; NHCS ICD-10 2e-v1 2017.

Data Guide, Dictionary, and Codebook: https://www.sandiegocounty.gov/content/dam/sdc/hhsa/programs/phs/CHS/Community%20Profiles/Public%20Health%20Services%20Codebook_Data%20Guide_Metadata_10.2.19.xlsx

The Child Development Center (CDC) market is experiencing robust growth, driven by increasing awareness of early childhood development's importance and rising prevalence of developmental disorders like autism. The market, estimated at $15 billion in 2025, is projected to grow at a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching approximately $25 billion by 2033. This growth is fueled by several factors, including government initiatives promoting early intervention programs, increased parental spending on childcare and educational services, and a growing demand for specialized centers catering to children with autism and other developmental needs. The segment focused on children with autism is experiencing particularly rapid expansion due to heightened awareness and improved diagnostic capabilities. Furthermore, the increasing number of dual-income households necessitates professional childcare, further boosting market demand. The market is segmented by application (normal children, autistic children, and others) and type of center (centers for intellectual, emotional, and physical development; early intervention and treatment centers). While centers focused on intellectual, emotional, and physical development constitute a larger segment currently, early intervention and treatment centers are exhibiting faster growth due to rising autism rates and increased focus on therapeutic interventions. Geographic variations exist, with developed regions like North America and Europe currently holding larger market shares, but developing economies are projected to witness significant growth in the coming years due to rising disposable incomes and increased awareness of CDC services. Competitive pressures are moderate with a mix of large national chains and smaller, localized providers. Key challenges include maintaining high quality of care while managing operational costs and ensuring skilled staff availability. The increasing use of technology in early childhood education presents a key opportunity for future growth and innovation.

BackgroundTo explore the geographical pattern and temporal trend of autism spectrum disorders (ASD) epidemiology from 1990 to 2019, and perform a bibliometric analysis of risk factors for ASD.MethodsIn this study, ASD epidemiology was estimated with prevalence, incidence, and disability-adjusted life-years (DALYs) of 204 countries and territories by sex, location, and sociodemographic index (SDI). Age-standardized rate (ASR) and estimated annual percentage change (EAPC) were used to quantify ASD temporal trends. Besides, the study performed a bibliometric analysis of ASD risk factors since 1990. Publications published were downloaded from the Web of Science Core Collection database, and were analyzed using CiteSpace.ResultsGlobally, there were estimated 28.3 million ASD prevalent cases (ASR, 369.4 per 100,000 populations), 603,790 incident cases (ASR, 9.3 per 100,000 populations) and 4.3 million DALYs (ASR, 56.3 per 100,000 populations) in 2019. Increases of autism spectrum disorders were noted in prevalent cases (39.3%), incidence (0.1%), and DALYs (38.7%) from 1990 to 2019. Age-standardized rates and EAPC showed stable trend worldwide over time. A total of 3,991 articles were retrieved from Web of Science, of which 3,590 were obtained for analysis after removing duplicate literatures. “Rehabilitation”, “Genetics & Heredity”, “Nanoscience & Nanotechnology”, “Biochemistry & Molecular biology”, “Psychology”, “Neurosciences”, and “Environmental Sciences” were the hotspots and frontier disciplines of ASD risk factors.ConclusionsDisease burden and risk factors of autism spectrum disorders remain global public health challenge since 1990 according to the GBD epidemiological estimates and bibliometric analysis. The findings help policy makers formulate public health policies concerning prevention targeted for risk factors, early diagnosis and life-long healthcare service of ASD. Increasing knowledge concerning the public awareness of risk factors is also warranted to address global ASD problem.

The prevalence rate of autism spectrum disorder among children aged eight years in Missouri was 14.2 per 1,000 children in 2010. In 2022, this rate was estimated to be 32.1 per 1,000 eight-year-olds. Autism spectrum disorder is a developmental disability characterized by deficits in social communication and interaction as well as repetitive behavior, interest, or activity patterns. This statistic displays the estimated prevalence of autism spectrum disorder among children aged 8 years in select U.S. states from 2010 to 2022.

The global Autism Spectrum Disorder (ASD) Screening Service market size was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.6 billion by 2033, growing at a CAGR of 5.9% during the forecast period. The rising prevalence of ASD, increasing awareness about early diagnosis and intervention, and technological advancements are driving the growth of the market. The increasing number of government initiatives and reimbursement policies for ASD screening are also contributing to the market growth. In terms of segmentation, the child application segment is expected to dominate the market, owing to the higher prevalence of ASD in children. The developmental screening service segment is projected to witness significant growth due to the increasing demand for early diagnosis and intervention. North America is currently the largest regional market, followed by Europe and Asia-Pacific. The market in North America is driven by the high prevalence of ASD, well-established healthcare infrastructure, and favorable reimbursement policies. However, the market in Asia-Pacific is expected to grow at the fastest rate during the forecast period, due to the increasing awareness about ASD and rising healthcare spending. The Autism Spectrum Disorder Screening Service market is a rapidly growing industry, driven by the increasing prevalence of autism spectrum disorder (ASD) and the need for early diagnosis and intervention. The market is expected to reach $1.5 billion by 2025, according to a recent report by Grand View Research.

The aim of this publication is to provide information about the key differences in healthcare between people with a learning disability and those without. It contains aggregated data on key health issues for people who are recorded by their GP as having a learning disability, and comparative data about a control group who are not recorded by their GP as having a learning disability. Six new indicators were introduced in the 2022-23 reporting year for patients with and without a recorded learning disability. These relate to: • Patients with an eating disorder • Patients with both an eating disorder and autism diagnosis • Patients with a diagnosis of autism who are currently treated with antidepressants More information on these changes can be found in the Data Quality section of this publication. Data has been collected from participating practices using EMIS and Cegedim Healthcare Systems GP systems.